Dyslipidemia Guidelines: What's New?

This episode is part of ACC's ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines. Join Drs. Pam Morris and Roger Blumenthal as they explore updates to the Dyslipidemia Guidelines, the patient populations who benefit most, and how to make sense of all of this new information. They provide a practical, evidence‑based discussion designed to support better decision‑making in everyday care.

This podcast is part of the ACC's Implementing the 2026 Dyslipidemia Guidelines: From Risk Stratification to Personalized Treatment online course, supported by Merck & Co. and Eli Lilly and Company. Visit the online course to access additional educational activities on this topic.